New market study, “Global HER2-Negative Breast Cancer", has been published By Hexa Reports

HER2-negative breast cancer is a subtype of breast cancer and is the condition when the HER2 is expressed less in the tumor. According to the American Society of Clinical Oncology, most of the patients with breast cancer are known to have HER2-negative breast cancer. HER2-negative breast cancer patients can also be hormone receptor positive (HR+). The HER2 protein is found on the outer surface of the breast cells, and the hormone receptors are found inside breast cells. The cancers that have detectable hormone receptors are known as HR+ breast cancer, and those with HER2-negative have a low level of HER2 gene or the HER2 protein. HER2-negative breast cancer can also be HR+ and then the most preferred therapy is hormone therapy. These patients can be treated with chemotherapy or targeted therapy to improve their condition.

Browse Detail Report With TOC @ http://www.hexareports.com/report/global-her2-negative-breast-cancer-market/details

Covered in this report

This report covers the present scenario and the growth prospects of the global HER2-negative breast cancer market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various off-label and branded drugs and the expected launch of drug candidates intended to be used in the treatment of HER2-negative breast cancer.

Table Of Content

PART 01: Executive summary

 Highlights

PART 02: Scope of the report

 Market overview

 Top vendor offerings

PART 03: Market research methodology

 Research methodology

 Economic indicators

Request A Sample copy of This Report @ http://www.hexareports.com/sample/50091

PART 04: Introduction

 Key market highlights

PART 05: Market landscape

 Market overview

 Market size and forecast

 Five forces analysis

PART 06: Market segmentation  by type of drug molecule

 Biologics

 Small molecules

PART 07: Market segmentation by route of administration

 Oral

 Parenteral

PART 08: Geographical segmentation

 Market segmentation by geography 2014-2019

 HER2-negative breast cancer market in Americas 2014-2019

 HER2-negative breast cancer market in EMEA 2014-2019

 HER2-negative breast cancer market in APAC 2014-2019

PART 09: Pipeline portfolio

 Key information about late-stage pipeline candidates

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

 Competitive scenario

 Key news

Browse Full Report @ http://www.hexareports.com/report/global-her2-negative-breast-cancer-market/details   

About Us:

Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Information:

Ryan Shaw

Felton Office Plaza,

6265 Highway 9,

Felton, California, 95018,

United States

Phone Number

1-800-489-3075

Email Us: sales@hexareports.com

Our Website: http://www.hexareports.com/